Onconova Therapeutics Inc.[ONTX] stock saw a move by -7.88% on Wednesday, touching 4.67 million. Based on the recent volume, Onconova Therapeutics Inc. stock traders appear to be active. The most recent trading volume of ONTX shares recorded 134.00M shares, which represents the daily volume of traded shares. Analysts estimates state that Onconova Therapeutics Inc. [ONTX] stock could reach median target price of $2.00.
Onconova Therapeutics Inc. [ONTX] stock additionally went up by 22.59% in the period of the 7 days, recording a drop in performance by -27.45% in the last 30 days. The yearly more of ONTX stock is set at -90.39% by far, with shares price recording returns by 16.48% in the latest quarter. Over the past six months, ONTX shares showcased -69.35% decrease. ONTX saw 4.45 change opposing the low price in the last 12 months, also recording 0.10 compared to high within the same period of time.
Onconova Therapeutics Inc. [NASDAQ:ONTX]: Analyst Rating and Earnings
Stock market traders frequently keep their eyes on what Wall Street experts as it relates to a potential investment. For Onconova Therapeutics Inc. [ONTX], the most recent analyst consensus recommendation available since its latest financial results for the quarter ending in 12/30/2019. On average, stock market experts give ONTX an Buy rating. The average 12-month price forecast for this stock is $0.33, with the high estimate being $2.00, the low estimate being $1.30 and the median estimate amounting to $2.00. This is compared to its latest closing price of $0.36.
Wall Street analysts provide their ratings on a scale of 1 to 5, and the current average score for Onconova Therapeutics Inc. [ONTX] is sitting at 4.33. This is compared to 1 month ago, when its average rating was 4.33.
Keep your eyes peeled for the soon-to-be-published financial results of this company, which are expected to be made public on 05/19/2020.
Fundamental Analysis of Onconova Therapeutics Inc. [ONTX]
The Enterprise Value to Sales for this firm is now -6.73. Onconova Therapeutics Inc. [ONTX] has a Price to Book Ratio of 2.22.
Onconova Therapeutics Inc. [ONTX] has 134.00M shares outstanding, amounting to a total market cap of 47.64M. Its stock price has been found in the range of 0.10 to 4.45. At its current price, it has moved down by -92.64% from its 52-week high, and it has moved up 218.89% from its 52-week low.
This stock’s Beta value is currently 1.99, which indicates that it is 16.46% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 42.81. This RSI score is good, suggesting this stock is neither overbought or oversold.
Conclusion: Is Onconova Therapeutics Inc. [ONTX] a Reliable Buy?
Shares of Onconova Therapeutics Inc. [ONTX], on the whole, present investors with both positive and negative signals. Wall Street analysts have mixed reviews when it comes to the 12-month price outlook, and this company’s financials show a combination of strengths and weaknesses. Based on the price performance, this investment is somewhat risky while presenting reasonable potential for ROI.